These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 34122497)
21. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
22. A Novel m Chen S; Zhang N; Zhang E; Wang T; Jiang L; Wang X; Zheng J Front Cell Dev Biol; 2020; 8():616972. PubMed ID: 33553151 [TBL] [Abstract][Full Text] [Related]
23. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma. Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783 [No Abstract] [Full Text] [Related]
24. Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers. Tao Z; Zhao Y; Chen X PeerJ; 2020; 8():e9589. PubMed ID: 32765970 [TBL] [Abstract][Full Text] [Related]
25. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients. Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244 [TBL] [Abstract][Full Text] [Related]
26. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
27. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma. Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964 [TBL] [Abstract][Full Text] [Related]
28. The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma. Zhao Z; Yang L; Fang S; Zheng L; Wu F; Chen W; Song J; Chen M; Ji J Front Oncol; 2020; 10():1435. PubMed ID: 32974160 [TBL] [Abstract][Full Text] [Related]
29. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database. Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL Front Genet; 2020; 11():810. PubMed ID: 33014010 [TBL] [Abstract][Full Text] [Related]
30. Upregulation of METTL14 mediates the elevation of PERP mRNA N Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065 [TBL] [Abstract][Full Text] [Related]
31. METTL14 suppresses cancer stem cell phenotype of colorectal cancer via regulating of β-catenin/NANOG. Sun CL; Chen J; Xing ZW; Tao GS J Cancer; 2023; 14(8):1407-1416. PubMed ID: 37283789 [TBL] [Abstract][Full Text] [Related]
32. The screening of pivotal gene expression signatures and biomarkers in renal carcinoma. Ruan H; Li S; Tong J; Cao Q; Song Z; Wang K; Huang Y; Bao L; Chen X; Yang H; Chen K; Zhang X J Cancer; 2019; 10(25):6384-6394. PubMed ID: 31772671 [TBL] [Abstract][Full Text] [Related]
33. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma. Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S Front Oncol; 2020; 10():718. PubMed ID: 32547941 [TBL] [Abstract][Full Text] [Related]
34. Clinical Significance of an m6A Reader Gene, Deng X; Jiang Q; Liu Z; Chen W Front Mol Biosci; 2020; 7():68. PubMed ID: 32391379 [TBL] [Abstract][Full Text] [Related]
35. A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma. Gao S; Ruan H; Liu J; Liu Y; Liu D; Tong J; Shi J; Yang H; Xu T; Zhang X Front Oncol; 2021; 11():678694. PubMed ID: 34367965 [TBL] [Abstract][Full Text] [Related]
36. The prognostic values of m6A RNA methylation regulators in uveal melanoma. Tang J; Wan Q; Lu J BMC Cancer; 2020 Jul; 20(1):674. PubMed ID: 32682400 [TBL] [Abstract][Full Text] [Related]
37. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database. Zhou J; Wang J; Hong B; Ma K; Xie H; Li L; Zhang K; Zhou B; Cai L; Gong K Aging (Albany NY); 2019 Mar; 11(6):1633-1647. PubMed ID: 30877265 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm. Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model. Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229 [TBL] [Abstract][Full Text] [Related]
40. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma. Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y Front Genet; 2020; 11():994. PubMed ID: 33193582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]